Zobrazeno 1 - 10
of 128
pro vyhledávání: '"European League Against Rheumatism"'
Autor:
Makara, Matthew, author
Publikováno v:
The Sjögren's Book, 2022.
Externí odkaz:
https://doi.org/10.1093/oso/9780197502112.003.0017
Publikováno v:
Научно-практическая ревматология, Vol 57, Iss 5, Pp 496-510 (2019)
A diversity of the clinical manifestations of systemic lupus erythematosus (SLE) and its undulating course with alternating remissions and exacerbations make this disease one of the most difficult ones to diagnose, treat, and evaluate the efficiency
Externí odkaz:
https://doaj.org/article/a440292f952e4392bfa4eac6a26e471e
Autor:
Diana Guavita-Navarro, Laura Gallego-Cardona, Ana María Arredondo, Hector Cubides, Jairo Cajamarca-Barón, Claudia Ibáñez, Alejandro Escobar, Adriana Rojas-Villarraga
Publikováno v:
Journal of Translational Autoimmunity, Vol 4, Iss , Pp 100133- (2021)
Background: /Objective: Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease with a wide range of clinical manifestations. The latest classification criteria, EULAR/ACR 2019, have not been validated in a Latin American population of
Externí odkaz:
https://doaj.org/article/202302a592584ea292744613a188ce68
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
T. V. Beketova
Publikováno v:
Современная ревматология, Vol 13, Iss 2, Pp 22-24 (2019)
The paper reviews the new European League Against Rheumatism (EULAR) guidelines covering a wide range of rheumatology issues discussed at the 2018 EULAR Congress.
Externí odkaz:
https://doaj.org/article/a202a27f5b19423992d85f9152ab990a
Publikováno v:
European Medical Journal Rheumatology, Vol 3, Iss 1, Pp 57-65 (2016)
This educational symposium was opened by Prof Ernest Choy, who introduced the concept of precision medicine and highlighted the importance of integrating current research with clinical experience to guide treatment decisions. He also highlighted the
Externí odkaz:
https://doaj.org/article/9fbefb1bb61f4a068f758b75e246ede0
Publikováno v:
European Medical Journal Rheumatology, Vol 3, Iss 1, Pp 28-35 (2016)
Three biosimilar products are now licensed for the treatment of rheumatic diseases in Europe. The European Medicines Agency (EMA) requires that similarity between a biosimilar and its reference product is demonstrated using a rigorous, stepwise proce
Externí odkaz:
https://doaj.org/article/47619c0fc73548b6ae03702721b2c5df
Publikováno v:
European Medical Journal Rheumatology, Vol 3, Iss 1, Pp 66-73 (2016)
Prof Josef Smolen opened the symposium and briefly described the aims of the meeting. Co-host Prof Constantino Pitzalis first discussed the pathophysiology of rheumatoid arthritis (RA), identifying the pro-inflammatory cytokines involved and explaini
Externí odkaz:
https://doaj.org/article/a62cb74c57a14e7c8531df07b09a91a8
Publikováno v:
European Medical Journal Rheumatology, Vol 3, Iss 1, Pp 48-56 (2016)
Targeted biologics have revolutionised the treatment and outlook of patients with inflammatory joint diseases. The combination of high-cost long-term therapy straining healthcare systems with impending expiry of key biologics patents has led to heigh
Externí odkaz:
https://doaj.org/article/0d74a43fbfcb4ce9a49f9fe0418b79be